Difference between revisions of "Clinical decision support (MU2)"
From OpenEMR Project Wiki
Bradymiller (talk | contribs) (Created page with "==Overview== ==MU Requirements== ===Per ONC=== :Taken from [http://www.ofr.gov/OFRUpload/OFRData/2012-20982_PI.pdf ONC Final Rule] <pre> </pre> ==Status== ==Proposal== ==Own...") |
Bradymiller (talk | contribs) |
||
Line 5: | Line 5: | ||
:Taken from [http://www.ofr.gov/OFRUpload/OFRData/2012-20982_PI.pdf ONC Final Rule] | :Taken from [http://www.ofr.gov/OFRUpload/OFRData/2012-20982_PI.pdf ONC Final Rule] | ||
<pre> | <pre> | ||
(8) Clinical decision support. (i) Evidence-based decision support interventions. Enable a limited | |||
set of identified users to select (i.e., activate) one or more electronic clinical decision support | |||
interventions (in addition to drug-drug and drug-allergy contraindication checking) based on | |||
each one and at least one combination of the following data: | |||
(A) Problem list; | |||
(B) Medication list; | |||
(C) Medication allergy list; | |||
(D) Demographics; | |||
(E) Laboratory tests and values/results; and | |||
(F) Vital signs. | |||
(ii) Linked referential clinical decision support. (A) EHR technology must be able to: | |||
(1) Electronically identify for a user diagnostic and therapeutic reference information; or | |||
(2) Electronically identify for a user diagnostic and therapeutic reference information in | |||
accordance with the standard specified at § 170.204(b) and the implementation | |||
specifications at § 170.204 (b)(1) or (2). | |||
(B) For paragraph (a)(8)(ii)(A) of this section, EHR technology must be able to | |||
electronically identify for a user diagnostic or therapeutic reference information based on | |||
each one and at least one combination of the following data referenced in paragraphs | |||
(a)(8)(i)(A) through (F) of this section: | |||
(iii) Clinical decision support configuration. (A) Enable interventions and reference | |||
resources specified in paragraphs (a)(8)(i) and (ii) of this section to be configured by a | |||
limited set of identified users (e.g., system administrator) based on a user’s role. | |||
(B) EHR technology must enable interventions to be electronically triggered: | |||
(1) Based on the data referenced in paragraphs (a)(8)(i)(A) through (F) of this section. | |||
(2) When a patient’s medications, medication allergies, and problems are incorporated | |||
from a transition of care/referral summary received pursuant to paragraph (b)(1)(iii) of | |||
this section. | |||
(3) Ambulatory setting only. When a patient’s laboratory tests and values/results are | |||
incorporated pursuant to paragraph (b)(5)(i)(A)(1) of this section. | |||
(iv) Automatically and electronically interact. Interventions triggered in accordance with | |||
paragraphs (a)(8)(i) through (iii) of this section must automatically and electronically occur when | |||
a user is interacting with EHR technology. | |||
(v) Source attributes. Enable a user to review the attributes as indicated for all clinical decision | |||
support resources: | |||
(A) For evidence-based decision support interventions under paragraph (a)(8)(i) of this | |||
section: | |||
(1) Bibliographic citation of the intervention (clinical research/guideline); | |||
(2) Developer of the intervention (translation from clinical research/guideline); | |||
(3) Funding source of the intervention development technical implementation; and | |||
(4) Release and, if applicable, revision date(s) of the intervention or reference source. | |||
(B) For linked referential clinical decision support in paragraph (a)(8)(ii) of this section and | |||
drug-drug, drug-allergy interaction checks in paragraph(a)(2) of this section, the developer | |||
of the intervention, and where clinically indicated, the bibliographic citation of the | |||
intervention (clinical research/guideline). | |||
</pre> | </pre> | ||
Revision as of 00:24, 9 September 2012
Overview
MU Requirements
Per ONC
- Taken from ONC Final Rule
(8) Clinical decision support. (i) Evidence-based decision support interventions. Enable a limited set of identified users to select (i.e., activate) one or more electronic clinical decision support interventions (in addition to drug-drug and drug-allergy contraindication checking) based on each one and at least one combination of the following data: (A) Problem list; (B) Medication list; (C) Medication allergy list; (D) Demographics; (E) Laboratory tests and values/results; and (F) Vital signs. (ii) Linked referential clinical decision support. (A) EHR technology must be able to: (1) Electronically identify for a user diagnostic and therapeutic reference information; or (2) Electronically identify for a user diagnostic and therapeutic reference information in accordance with the standard specified at § 170.204(b) and the implementation specifications at § 170.204 (b)(1) or (2). (B) For paragraph (a)(8)(ii)(A) of this section, EHR technology must be able to electronically identify for a user diagnostic or therapeutic reference information based on each one and at least one combination of the following data referenced in paragraphs (a)(8)(i)(A) through (F) of this section: (iii) Clinical decision support configuration. (A) Enable interventions and reference resources specified in paragraphs (a)(8)(i) and (ii) of this section to be configured by a limited set of identified users (e.g., system administrator) based on a user’s role. (B) EHR technology must enable interventions to be electronically triggered: (1) Based on the data referenced in paragraphs (a)(8)(i)(A) through (F) of this section. (2) When a patient’s medications, medication allergies, and problems are incorporated from a transition of care/referral summary received pursuant to paragraph (b)(1)(iii) of this section. (3) Ambulatory setting only. When a patient’s laboratory tests and values/results are incorporated pursuant to paragraph (b)(5)(i)(A)(1) of this section. (iv) Automatically and electronically interact. Interventions triggered in accordance with paragraphs (a)(8)(i) through (iii) of this section must automatically and electronically occur when a user is interacting with EHR technology. (v) Source attributes. Enable a user to review the attributes as indicated for all clinical decision support resources: (A) For evidence-based decision support interventions under paragraph (a)(8)(i) of this section: (1) Bibliographic citation of the intervention (clinical research/guideline); (2) Developer of the intervention (translation from clinical research/guideline); (3) Funding source of the intervention development technical implementation; and (4) Release and, if applicable, revision date(s) of the intervention or reference source. (B) For linked referential clinical decision support in paragraph (a)(8)(ii) of this section and drug-drug, drug-allergy interaction checks in paragraph(a)(2) of this section, the developer of the intervention, and where clinically indicated, the bibliographic citation of the intervention (clinical research/guideline).